首页 | 本学科首页   官方微博 | 高级检索  
检索        

HLCDG1基因siRNA表达质粒的构建及其对A549细胞周期和增殖的影响
引用本文:邹飞雁,李峰,陈主初,贺智敏,吕辉,刘孝荣,欧阳咏梅.HLCDG1基因siRNA表达质粒的构建及其对A549细胞周期和增殖的影响[J].中国病理生理杂志,2006,22(7):1256-1262.
作者姓名:邹飞雁  李峰  陈主初  贺智敏  吕辉  刘孝荣  欧阳咏梅
作者单位:1中南大学肿瘤研究所细胞生物室, 湖南 长沙 410078;2暨南大学生殖免疫研究所, 广东 广州 510632;3中南大学湘雅医院医学实验研究中心,卫生部肿瘤蛋白质组学重点实验室, 湖南 长沙 410008
基金项目:国家高技术研究发展计划(863计划);中国博士后科学基金
摘    要:目的:本研究旨在应用RNA干扰技术,诱导转基因肺癌细胞HLCDG1基因沉默并观察其对肺癌细胞周期和增殖的影响。 方法:构建HLCDG1基因短小干扰双链RNA表达载体,筛选HLCDG1基因表达沉默的肺癌细胞株并应用MTT和流式细胞仪分析这一肺癌细胞株增殖和细胞周期分布状况。 结果:根据siRNA表达载体的设计原则,构建了能在哺乳动物细胞稳定表达的siRNA载体5个(4个位点匹配实验组和1个位点错配对照组),依次命名为pHL-si-1、pHL-si-2、pHL-si-3、pHL-si-4 和 pHL-si-c。上述载体分别与表达HLCDG1的重组体pcDNA3.1(+)/HLCDG1共转染A549细胞,筛选到一株共转染pHL-si-1载体和pcDNA3.1(+)/HLCDG1重组体的A549细胞,它几无HLCDG1基因表达,这株细胞暂命名为A549-HLCDG1-si-1。MTT和流式细胞仪分析表明,A549-HLCDG1-si-1细胞增殖能力明显提高,进入S期和G2+M期增多,滞留G1期减少。 结论:采用RNAi技术特异阻断HLCDG1基因表达,验证了HLCDG1基因对A549肺癌细胞有生长抑制作用。

关 键 词:基因  HLCDG1  短小干扰双链RNA  A549细胞  细胞周期  
文章编号:1000-4718(2006)07-1256-07
收稿时间:2005-05-09
修稿时间:2005-05-092005-06-29

Construction of HLCDG1 gene siRNA expression vector and its regulation on cell cycle and proliferation in A549 cells
ZOU Fei-yan,LI Feng,CHEN Zhu-chu,HE Zhi-min,LV Hui,LIU Xiao-rong,OUYANG Yong-mei.Construction of HLCDG1 gene siRNA expression vector and its regulation on cell cycle and proliferation in A549 cells[J].Chinese Journal of Pathophysiology,2006,22(7):1256-1262.
Authors:ZOU Fei-yan  LI Feng  CHEN Zhu-chu  HE Zhi-min  LV Hui  LIU Xiao-rong  OUYANG Yong-mei
Institution:1Laboratory of Cell Biology, Cancer Research Institute, Central South University, Changsha 410078, China;2Institute for Reproductive Immunology Research, Jinan University, Guangzhou 510632, China
Abstract:AIM: HLCDG1 is a novel gene cloned recently, and its expression inhibits significantly the growth of A549 cells and tumorigenesis of A549 cells transplanted in nude mice. In this study, our aim was to construct HLCDG1 gene short/small interference double-strand RNA (siRNAs) expression vector and to observe its influence on cell cycle and proliferation of A549 cells. METHODS: Using RNA interference (RNAi) techniques, a DNA vector-driven siRNAs expression vector was constructed, and a lung carcinoma cell line stably expressing siRNAs was also selected. Sequentially, using flow cytometry analysis and MTT assay, the changes of cell cycle and cell proliferation in this cell line were observed. RESULTS: Four site-match and one site-mismatch plasmids were constructed, which were named pHL-si-1, pHL-si-2, pHL-si-3, pHL-si-4 and pHL-si-c. These plasmids were co-transfected with a pcDNA3.1(+)/HLCDG1 plasmid into A549 cells, respectively. Among five co-transfected A549 cell lines, a A549 cell line co-transfected by the pcDNA3.1(+)/HLCDG1 and pHL-si-1 plasmids, namely A549-HLCDG1-si-1, showed nearly complete inhibition of HLCDG1 expression. MTT assay and flow cytometry analysis indicated that A549-HLCDG1-si-1 cells, namely the HLCDG1 gene-silencing cells, got a faster growth compared with other HLCDG1 expression cell lines, and that HLCDG1 gene-silencing induced A549-HLCDG1-si-1 cells into S phase and G_2+M phase significantly. CONCLUSION: These results suggest that the HLCDG1 gene is proved to have a markedly inhibitory effect on growth in A549 lung carcinoma cells. This study might provide some understanding of the biological function and molecular mechanism of HLCDG1 gene.
Keywords:Genes  HLCDG1  Short/small interference double -strand RNA  A549 cells  Cell cycle
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号